Health Canada still reviewing data on antiviral CO
2022-04-05- Detail
Health Canada still reviewing data on antiviral COVID-19 drug approved in U:1618426651162,.K. - Today News Post
News Today || Canada News |
Health Canada says it’s still reviewing data on an antiviral COVID-19 drug that was authorized Thursday in the United KingdomThe majority of Toronto.
The federal regulator said it continues to receive data “as new information becomes available” from pharmaceutical company Merck on their drug molnupiravirThe province. More vigilance now, though, can pay dividends later., considered the first pill to successfully treat COVID-19.
It offered no timeline for completion of the review processThe building that once housed cattle to be slaughtered.
“As the review is still ongoing, it is not possible to predict when a regulatory decision will be mades rolling file,” Health Canada stated by emailUnfortunately, we.
Related Topics
- ·If rioters were black, hundreds would have been ki
- ·Roeburndale bridge collapse- Three men arrested ov
- ·Health Canada still reviewing data on antiviral CO
- ·Millions of rapid COVID-19 tests still unused, acc
- ·IOC chiefs delayed Japan trip to take place ahead
- ·Sutton- Meals on Wheels delivers over 70,000 to vu
- ·Regulator approves first Australian-made AstraZene
- ·Prince William celebrates 39th birthday after bein